Study of Palbociclib in MLL-rearranged Acute Leukemias

Clinical trial NCT02310243 · UNKNOWN

Trial details

NCT number: NCT02310243
Sponsor: University of Ulm
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia

Start date: 2015-07-01
Primary completion: 2019-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.